Elsinga PH - Search Results

1

A closer look at the synthesis of 2-[¹⁸F]fluoroethyl tosylate to minimize the formation of volatile side-products.

Pijeira MSO, Dos Santos SN, Araujo YB, Lapolli AL, Wandermuren MN, Riera ZR, Carvalho I, Elsinga PH, Bernardes ES. Pijeira MSO, et al. Among authors: elsinga ph. EJNMMI Radiopharm Chem. 2022 Oct 6;7(1):26. doi: 10.1186/s41181-022-00179-8. EJNMMI Radiopharm Chem. 2022. PMID: 36201072 Free PMC article.

2

Nomenclature for radiopharmaceuticals, consultation of your opinion!

Elsinga PH. Elsinga PH. EJNMMI Radiopharm Chem. 2017;2(1):1. doi: 10.1186/s41181-017-0022-z. Epub 2017 Jan 18. EJNMMI Radiopharm Chem. 2017. PMID: 29527562 Free PMC article. No abstract available.

3

Editorial - EJNMMI radiopharmacy and chemistry.

Elsinga PH. Elsinga PH. EJNMMI Radiopharm Chem. 2017;1(1):2. doi: 10.1186/s41181-016-0006-4. Epub 2016 Mar 21. EJNMMI Radiopharm Chem. 2017. PMID: 29564379 Free PMC article. No abstract available.

4

Improved GMP-compliant multi-dose production and quality control of 6-[¹⁸F]fluoro-L-DOPA.

Luurtsema G, Boersma HH, Schepers M, de Vries AMT, Maas B, Zijlma R, de Vries EFJ, Elsinga PH. Luurtsema G, et al. Among authors: elsinga ph. EJNMMI Radiopharm Chem. 2017;1(1):7. doi: 10.1186/s41181-016-0009-1. Epub 2016 Apr 4. EJNMMI Radiopharm Chem. 2017. PMID: 29564384 Free PMC article.

5

A new approach to produce [¹⁸F]MC225 via one-step synthesis, a PET radiotracer for measuring P-gp function.

Garcia-Varela L, Attia K, Sembrano JC, Jacquet O, Antunes IF, Kwizera C, Visser TJ, Dierckx RAJO, Elsinga PH, Luurtsema G. Garcia-Varela L, et al. Among authors: elsinga ph. EJNMMI Radiopharm Chem. 2021 Jul 15;6(1):24. doi: 10.1186/s41181-021-00139-8. EJNMMI Radiopharm Chem. 2021. PMID: 34264435 Free PMC article.

6

The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?

Peñuelas I, Vugts DJ, Decristoforo C, Elsinga PH. Peñuelas I, et al. Among authors: elsinga ph. EJNMMI Radiopharm Chem. 2019 Jan 11;4(1):2. doi: 10.1186/s41181-019-0055-6. EJNMMI Radiopharm Chem. 2019. PMID: 31659485 Free PMC article. No abstract available.

7

New sensitive method for HEPES quantification in ⁶⁸Ga-radiopharmaceuticals.

Antunes IF, Franssen GM, Zijlma R, Laverman P, Boersma HH, Elsinga PH. Antunes IF, et al. Among authors: elsinga ph. EJNMMI Radiopharm Chem. 2020 May 14;5(1):12. doi: 10.1186/s41181-020-00093-x. EJNMMI Radiopharm Chem. 2020. PMID: 32410136 Free PMC article.

8

The effects of molar activity on [¹⁸F]FDOPA uptake in patients with neuroendocrine tumors.

Stormezand GN, Schreuder RSBH, Brouwers AH, Slart RHJA, Elsinga PH, Walenkamp AME, Dierckx RAJO, Glaudemans AWJM, Luurtsema G. Stormezand GN, et al. Among authors: elsinga ph. EJNMMI Res. 2021 Sep 8;11(1):88. doi: 10.1186/s13550-021-00829-z. EJNMMI Res. 2021. PMID: 34495420 Free PMC article.

9

EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality.

Luurtsema G, Pichler V, Bongarzone S, Seimbille Y, Elsinga P, Gee A, Vercouillie J. Luurtsema G, et al. EJNMMI Radiopharm Chem. 2021 Oct 9;6(1):34. doi: 10.1186/s41181-021-00149-6. EJNMMI Radiopharm Chem. 2021. PMID: 34628570 Free PMC article.

10

A proof-of-concept study on the use of a fluorescein-based ¹⁸F-tracer for pretargeted PET.

Helbert H, Ploeg EM, Samplonius DF, Blok SN, Antunes IF, Böhmer VI, Luurtsema G, Dierckx RAJO, Feringa BL, Elsinga PH, Szymanski W, Helfrich W. Helbert H, et al. Among authors: elsinga ph. EJNMMI Radiopharm Chem. 2022 Mar 3;7(1):3. doi: 10.1186/s41181-022-00155-2. EJNMMI Radiopharm Chem. 2022. PMID: 35239034 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

255 results

Search Page